• Product NameRisedronate Sodium
• Brief DescriptionInhibitors
• Purification99.83%
• Biological ActivityRisedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
• Target NameHBV inhibitor; Others inhibitor
• CAS No. 115436-72-1
• Calculated MW 305.09
• Formulation C7H10NNaO7P2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism system
  SMILES:O.O.O.O.O.[Na+].OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O.OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O
  Pathways:Microbiology&virology; Others
  Receptor:HAP; FPS
  Boling pt:
  Melting pt:692.3C
  Solubility:Water: 2 mg/mL (6.55 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Bergstrom JD, et al. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting